Table 2 Results from the univariante analysis
OR (IC95%) | P | |
|---|---|---|
Age > 60 years | 0.86 (0.40–1.83) | 0.700 |
Length of stay > 7 days | 6.52 (4.84–8.52) | < 0.001 |
APACHE II > 20 | 1.98 (0.89–2.62) | 0.092 |
Hematologic disease | 0.84 (0.17–3.97) | 0.825 |
Solid Organ Transplantation | 1.59 (0.31–8.26) | 0.580 |
Origin | 1.38 (1.21–1.57) | 0.168 |
Immunosuppression | 1.27 (0.47–3.40) | 0.641 |
Diabetes | 0.63 (0.26–1.56) | 0.320 |
Cirrhosis | 1.92 (0.36–10.37) | 0.477 |
1COPD | 0.89 (0.82–1.74) | 0.380 |
Mechanical ventilation | 1.34 (0.61–2.95) | 0.465 |
Renal replacement therapy | 1.66 (0.91–2.14) | 0.134 |
Parenteral Nutrition | 2.18 (1.01–4.69) | 0.045 |
Respiratory infection | 2.05 (0.93–4.53) | 0.074 |
Sepsis/Septic Shock | 0.39 (0.04–2.69) | 0.306 |
Antibiotics > 48 h | 5.60 (3.92–7.98) | < 0.001 |
Carbapenem | 1.33 (0.93–1.89) | 0.108 |
Quinolones | 1.21 (0.85–1.70) | 0.297 |
2IBL | 3.75 (2.83–4.97) | < 0.001 |
Cephalosporin | 1.87 (1.38–2.53) | < 0.001 |
Amynoglycosides | 3.78 (2.67–5.37) | < 0.001 |
Linezolid | 3.02 (1.21–4.17) | < 0.001 |
3SDD | 0.45 (0.05–3.64) | 0.454 |